Clinical Trial

A Study of SGB-7342 in Subjects With Obesity or Overweight

Name: A Study of SGB-7342 in Subjects With Obesity or Overweight — clinical trial record (NCT07324850)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety and tolerability of subcutaneously administered SGB-7342 in adult subjects with obesity and overweight.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-06.

Trial Details

NCT Number	NCT07324850
Lead Sponsor	Suzhou Sanegene Bio Inc.
Conditions	Obesity & Overweight
Enrollment	45 participants
Start Date	2026-01-12
Primary Completion	2026-10-28 (estimated)
Study Completion	2027-04-14 (estimated)
Updated on ClinicalTrials.gov	2026-01-09